Cell Line |
DescriptionSpecies |
Characteristics |
V |
TE |
 Photo |
| Â HUMAN |
|
|
|
|
|
| Â HeLa |
Human Cervical Carcinoma Cells |
Epithelial, Immortalized
Adherent |
95% |
95% |
 YES |
| Â HeLa-K |
Human Cervical Carcinoma Cells |
Epithelial, Immortalized
Adherent
|
90% |
90% |
 |
 293
(HEK293) |
Human Embryonic Kidney Cells |
Epithelial , Adherent
Adenovirus type 5 |
90%
|
90% |
 |
 293
(HEK293) |
Human Embryonic Kidney Cells |
 Epithelial , Adherent |
90% |
 70% |
Yes |
 293T
(HEK293T) |
Human Embryonic Kidney Cells |
Epithelial , Adherent
SV40 large T antigen |
90% |
95% |
 Yes |
| Â TIG-3 |
Human Embryonic Lung Fibroblasts |
Adherent
|
 90% |
 80% |
Yes |
| Â TIG-7 |
Human Embryonic Lung Fibroblasts |
Diploid, Normal
Adherent |
 89%
(FACS) |
76%
(FACS) |
Yes |
| MRC-5 |
Human Embryonic Lung Fibroblasts |
 Diploid, Normal
Adherent |
85% |
90% |
 Yes |
| SUSM-1 |
Human Fibroblasts |
Fetal Liver, Epithelial, Normal, Immortalized |
 77%
(FACS) |
 71%
(FACS) |
Yes |
| Â KMST-6 |
Human Fibroblasts |
Whole Embryo, Epithelial
|
 70% |
 60% |
Yes |
| Â hTERT-BJ1 |
Human Fibroblast |
Normal, Immortalized, Adherent |
 Good |
 31%
(FACS) |
 |
| Â HUVEC |
Human Umbilical Vein Endothelial Cells |
 Normal, Adherent |
 70% |
75% |
|
| Â HT1080 |
Human Fibrosarcoma Cells |
Connective Tissue
|
 93% |
81% |
Yes |
| Â MIA-PaCa-2 |
Human Pancreatic Carcinoma cells |
 Epithelial , Adherent |
 80% |
 77% |
Yes |
| Â HepG2 |
Human Hepatoma cells |
Epithelial , Adherent |
 80% |
 76% |
Yes |
| Â HuH-7 |
Human Hepatoma Cells |
Epithelial , Adherent |
 70% |
 60% |
Yes |
| Â H69 |
Human Small-Cell Lung Cancer cells |
 Adherent |
 90% |
 85% |
 Yes |
|
(NCI-H1299)
|
Human Lung Cancer Cells |
Non-Small, Epithelial
Adherent
|
 90% |
 90% |
 |
| Â HSC-2 |
Human Squamous Carcinoma Cells |
Oral , Adherent |
 90-95% |
 98% |
Yes |
| Â HSC-3 |
Human Squamous Carcinoma Cells |
Tongue , Adherent |
 90-95% |
 98% |
Yes |
| Â HSC-4 |
Human Squamous Carcinoma Cells |
Tongue, Adherent |
 80% |
 34% |
Yes |
| Â Ca9-22 |
Human Squamous Carcinoma Cells |
Gingival, Adherent |
 60% |
 60% |
Yes |
| Â HGF |
Human Gingival Fibroblasts |
Normal, Adherent |
 Excellent |
 Excellent |
Yes |
| Â MCF-7 |
Human Breast Cancer Cells |
Epithelial, Adherent |
 90% |
 90-95% |
Yes |
| Â T47D |
Human Breast Cancer Cells |
Ductal Carcinoma
Epithelial, Adherent |
 90% |
 80-90% |
 |
| Â BT-20 |
BT-20 Human Brest Cancer Cells |
 Normal, Mammary Epithelial, Adherent |
 70% |
 80% |
 Yes |
| Â MCF-10A |
Human Breast Cells |
Normal, Mammary Epithelial, Adherent |
 Excellent |
 Excellent |
Yes |
| Â NUGC-3 |
Human Gastric Carcinoma Cells |
Adherent |
 73%
(FACS) |
 68%
(FACS) |
 |
| Â A549 |
Human Lung Adenocarcinoma Cells |
Epithelial, Adherent |
 80-90% |
 90% |
 |
| Â TE-1 |
Human Esophageal Carcinoma Cells |
Adherent |
 80-90% |
 41% |
Yes |
| Â TE-8 |
Human Esophageal Carcinoma Cells |
Adherent |
 80-90% |
 40% |
 Yes |
| Â LNCaP |
Human Prostate Carcinoma |
Epithelial, Adherent |
 71%
(FACS) |
 90%
(FACS) |
 |
| Â PC-3 |
Human Prostate Cancer Cells |
Epithelial, Adherent |
 90% |
 95% |
 |
| Â RKO |
Human Colorectal Carcinoma Cells |
Adherent |
 80% |
 40% |
 |
| Â SKOV-3 |
Human Ovarian Carcinoma Cells |
Adherent |
 90% |
 90% |
Yes |
| Â OVCAR-3 |
Human Ovarian Carcinoma Cells |
Adherent |
 90% |
 79% |
Yes |
| Â RMG-1 |
Human Ovarian Clear CellAdenocarcinoma |
Adherent |
 97% |
 67% |
Yes |
| Â CCS |
Clear Cell Sarcoma |
Adherent |
 47% |
 55% |
 |
| Â SK-N-SH |
Human Neuroblastoma Cells |
Epithelial, Adherent |
 95% |
 95% |
Yes |
| Â SH-SY5Y |
Human Neuroblastoma Cells |
Adherent |
 60% |
 90% |
 Yes |
| Â KG-1-C |
Human Oligodendroglial Cells |
Adherent |
 85% |
 60% |
Yes |
| Â A172 |
Human Glioblastoma Cells |
Adherent |
 80-90% |
 70% |
 Yes |
| Â 1321N1 |
Human Astrocytoma Cells |
Adherent |
 80% |
 80% |
Yes |
| Â HaCaT |
Human Keratinocyte Cells |
Normal, Immortalized
Adherent |
 40% |
 80% |
 Yes |
| Â CCD1079sk |
Human Skin Fibroblasts |
Adherent |
 40% |
 53%
(FACS) |
 Yes |
| Â iHAM-4 |
Human Amniotic Mesenchymal Cells |
Adherent |
 59% |
 95% |
 |
| Â iHAE-7 |
Human Amniotic Epithelial Cells |
Adherent |
 70% |
 40% |
 |
| Â HTR-8/Svneo |
Human Trophoblast Cells |
 Adherent |
 95% |
 67% |
 Yes |
| Â RPE |
Retinal Pigment Epithelium Cells |
Adherent |
 90% |
 70% |
 |
| Â RPTEC |
Renal Proximal Tubule Epithelial Cells |
 Adherent |
 70% |
 85% |
 |
| Â UT-7/TPO |
Human Megakaryocytic |
 Suspension |
 51% |
 46% |
 Yes |
| Â Jurkat |
Human T-cell Leukemia Cells |
Round Single, Blood, Suspension |
 90% |
 85% |
 Yes |
| Â Nalm-6 |
Human B-cell Precursor Leukemia Cells |
Blood, Suspension |
67%
(FACS) |
 70%
(FACS) |
 |
| Â MY |
Human Acute Lymphocytic Leukemia Cells |
Myelomonocytic, Suspension |
 94%
(FACS) |
 22%
(FACS) |
 |
| Â PALL-2 |
Human Acute Leukemia Cells |
Acute Lymphoblastic |
 60% |
 27%
(FACS) |
 |
 KG-1
|
Human Acute Myeloid Leukemia |
 Suspension |
 50% |
 50% |
 Yes |
| Â USCD/AML1 |
Human Leukemia Cells |
Suspension |
 50% |
 50% |
 |
| Â Namalwa |
Human Burkitt’s Lymphoma Cells |
B lymphocyte, Blood
Suspension |
 70% |
75% |
 |
| Â Raji |
Human Burkitt’s Lymphoma Cells |
B lymphocyte, Blood
Suspension |
 74%
(FACS) |
 53%
(FACS) |
 |
| Â Mutu I |
Human Burkitt Lymphoma Cells |
EBV Positive, Suspension |
 87%
(FACS) |
 91%
(FACS) |
 Yes |
| Â Mutu III |
Human Burkitt Lymphoma Cells |
EBV Positive, Suspension |
 54%
(FACS) |
 92%
(FACS) |
 |
| Â HL-60 |
Human Promyelocytic Leukemia Cells |
Suspension |
 80% |
 80% |
 |
| Â LCL |
Human Burkitt’s Lymphoma Cells |
Immortalized, Suspension |
 55%
(FACS) |
 43%
(FACS) |
 Yes |
|
 Ramos-
BlueTM
|
Human Burkitt’s Lymphoma Cells |
B lymphocyte, Suspension |
 80% |
 55% |
 Yes |
| Â KU812 |
Human basophilic leukaemia Cells |
Suspension |
 96%
(FACS) |
 42%
(FACS) |
 |
| Â K562 |
Human Chronic Myelogenous Leukemia Cells |
Suspension |
 91%
(FACS) |
 99%
(FACS) |
 Yes |
| Â THP-1 |
Human Acute monocytic Leukemia Cells |
Suspension |
 76% |
 63% |
 Yes |
| MOUSE/RAT |
 |
 |
 |
 |
| Â NIH/3T3 |
Mouse Embryonic Fibroblasts |
Swiss NIH , Embryo
Adherent |
 74%
(FACS) |
 82%
(FACS) |
 Yes |
| Â 3T3-L1 |
Mouse Preadipocyte |
Fibroblast like |
 90% |
90% |
 Yes |
| Â MEF |
Mouse Embryonic Fibroblasts |
Adherent |
 80% |
 90% |
 Yes |
| Â MEF |
Mouse Embryonic Fibroblasts
|
 Adherent |
 75% |
 70% |
 Yes |
| Â P19C6 |
Mouse Embryonic Carcinoma Cells |
 Adherent |
 90% |
 50% |
 Yes |
| Â L |
Mouse Fibroblasts |
Adherent |
 90% |
65% |
 Yes |
| Â MC3T3-E1 |
Mouse Osteoblastic Cells |
Fibroblastic, Adherent |
 85% |
75% |
 Yes |
|
 LLc1
|
Lewis lung Cell Carcinoma 1 Cells |
Adherent |
 87%
(FACS) |
 81%
(FACS) |
 Yes |
| Â C2C12 |
Mouse Myoblast Cells |
Adherent |
 80% |
 70% |
Yes |
| Â 4T1 |
Mouse Breast Cancer Cells |
Adherent |
 90% |
 95% |
 Yes |
| Â Colon-26 |
Mouse colon adenocarcinoma Cells |
Adherent |
 95% |
 90% |
 Yes |
| Â MS-1 |
Mouse Pancreatic Endothelial Cells |
Adherent |
 90% |
 90% |
 |
| Â |
ddy Mouse Endometrial Cells |
Fibroblast, Adherent |
 60% |
 80% |
 |
| Â Neuro-2a |
Mouse Neuroblastoma Cells |
 Adherent |
 90% |
 90% |
 Yes |
| Â BV-2 |
Mouse Microglial Cells |
 Adherent |
 92% |
 60% |
 Yes |
| Â WR19L |
Mouse T-cell lymphoma Cells |
Suspension |
 92%
(FACS) |
 60%
(FACS) |
 Yes |
| Â BA/F3 |
Mouse pro-B cells |
 Suspension |
 90% |
 90% |
 |
| Â RAW264.7 |
Mouse Macrophage-like Cells |
Monocyte-like, Adherent |
 70% |
 56% |
 Yes |
| Â MIN6 |
Mouse Pancreatic Beta Cells |
Suspension |
 57%
(FACS) |
 71%
(FACS) |
 Yes |
| Â |
Mouse Pancreatic Islet Beta Cells |
 |
 60% |
 40% |
 Yes |
| Â MEL |
Mouse Erythroleukemia Cells |
Suspension |
 70%
(FACS) |
 50%
(FACS) |
 |
| Â XS106 |
Mouse Dendritic Cells |
Suspension |
 61% |
 45% |
 Yes |
| Â mDC |
Mouse Myeloid Dendritic Cells |
Suspension |
 79%
(FACS) |
 72%
(FACS) |
 |
| Â MC/9 |
Mouse Mast Cells |
Suspension |
 76%
(FACS) |
 84
(FACS) |
 Yes |
| Â BMBa |
Mouse Bone marrow-derived basophils |
Suspension |
 45%
(FACS) |
 67%
(FACS) |
 Yes |
| Â TS |
Mouse Trophoblast Stem Cells |
Adherent |
 59% |
 47% |
 Yes |
| Â ATDC5 |
 Mouse Pre-chondrocytic Cells |
 |
 62% |
 14% |
 Yes |
| Â PC12 |
Rat Adrenal Pheochromocytoma Cells |
Adherent |
 90% |
 70% |
 Yes |
| Â H9c2 |
Rat Ventricular Myoblasts |
 Skeletal Muscle-like
Adherent |
 71%
(FACS) |
82%
(FACS)Â |
 Yes |
| Â REF |
Rat Embryonic Fibroblasts |
 Adherent |
 90% |
99% |
Yes |
| Â RDF |
Rat Dermal Fibroblasts |
Adherent |
90% |
40% |
 |
| Â C6 |
Rat Glioma Cells |
Fibroblast-like, GFAP Positive, Adherent |
 80% |
 67% |
 Yes |
| Â RSC96 |
Rat Schwann Cells |
Adherent |
 70% |
 85% |
 Yes |
| Â TtT/GF |
Rat Anterior Pituitary Cells |
Folliculostellate, Adherent |
 65% |
 83% |
Yes |
| Â UMR106 |
Rat Osteoblastic Cells |
Adherent |
 80% |
 70% |
 |
|
 HAMSTER
|
|
|
|
|
|
| Â CHO |
Chinese Hamster Ovary Cells |
Epithelial, Adherent |
 74% |
 90% |
 Yes |
| Â CHO-K1 |
Chinese Hamster Ovary Cells |
Epithelial, Adherent |
 95% |
 95% |
 Yes |
| Â CHO-S |
Chinese Hamster Ovary Cells |
Epithelial, Suspension |
 Excellent |
 56%
(FACS) |
 |
|
 VARIOUS
|
 |
 |
 |
 |
 |
| Â DT40 |
Chicken B Cells |
Suspension |
 38% |
 40%
(FACS) |
 Yes |
| Â MDCK |
Madrin-Darby Canine Kidney Cells |
Epithelial-like, Adherent |
 90% |
 95% |
 Yes |
| Â BFF |
Bovine Fetal Fibroblasts |
 Adherent |
 78%
(FACS) |
 72%
(FACS)
|
 Yes |
| Â A6 |
Xenopus Kidney Epithelial Cells |
 Adherent |
 90% |
 60% |
 Yes |
| Â GTS9 |
Ginbuna Thymus Cells |
Adherent |
 50% |
 30% |
 Yes |
| Â Vero |
African Green Monkey Kidney Cells |
 Epithelial-like, Adherent |
58% |
 35% |
 |
| Â SEC |
Bovine T Cells |
 Suspension |
 80% |
21%
(FACS)Â |
 |
| Â |
|
 |
 |
 |
 |
|
|
|
|
|
|